Literature DB >> 15653264

Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment.

Bryan T Woods1, Kimberley E Ward, Edwin H Johnson.   

Abstract

BACKGROUND: Whole brain volume (BV) is significantly reduced in groups of schizophrenic patients, but there is disagreement as to when in relation to onset of illness these losses occur. Given what is known about the normal development and lifetime course of BV, intraventricular volume (IVV), extracerebral volume (ECV), and intracranial volume (ICV) changes, it is possible to allocate (within a narrow range of uncertainty) excessive brain volume loss (EBVL) to either the time before or the time after attainment of maximum brain volume (BVmax).
METHOD: Decreases in patient ICV relative to control ICV reflect early reductions in brain growth, while increases in ECV reflect later BV losses. There is however uncertainty as whether any relative increases in patient IVV occur early, later, or both. IVV differences were first assumed to be of early origin, so that early EBVL was measured by ICV-IVV differences and later EBVL by ECV differences alone. The IVV differences were then assumed to be of later origin, so that early EBVL was measured by ICV differences alone, and later EBVL by ECV+IVV differences. The results taken together delineate the maximum and minimum values for early and later losses.
RESULTS: Patient-control volume differences in BV and ICV for 20 published magnetic resonance imaging (MRI) studies of schizophrenic patients (n=982) and controls (n=1049), and differences in ECV for 17 of the same 20 studies, comprising 889 patients and 942 controls, showed a significant patient BV decrease of 34 cc's (t=-4.94, df=19, p<0.0001), ICV decrease of 20.1 cc's (t=-2.64, df=19, p<0.02) and ECV Increase of 14.1 cc's (t=3.65, df=16, p<0.001). In the 17 studies which included ECV and IVV, as well as ICV differences, the patient ICV-IVV decrease was 20.2 cc's (t=-2.56, df=16, p<0.05) and the ECV+IVV increase was 17.1 cc's (t=-4.11, df=16, p<0.001).
CONCLUSION: There is a small but significant whole brain EBVL in schizophrenia patients both before and after BV(max), regardless of when excessive IVV enlargement is assumed to occur.

Entities:  

Mesh:

Year:  2005        PMID: 15653264     DOI: 10.1016/j.schres.2004.05.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.

Authors:  Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni
Journal:  Schizophr Bull       Date:  2008-11-17       Impact factor: 9.306

Review 2.  [Frontal brain volume reduction due to antipsychotic drugs?].

Authors:  V Aderhold; S Weinmann; C Hägele; A Heinz
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

3.  Antibodies directed to Neisseria gonorrhoeae impair nerve growth factor-dependent neurite outgrowth in Rat PC12 cells.

Authors:  B Reuss
Journal:  J Mol Neurosci       Date:  2013-11-08       Impact factor: 3.444

4.  Hippocampal Subregions Across the Psychosis Spectrum.

Authors:  Teresa Vargas; Derek J Dean; Kenneth Juston Osborne; Tina Gupta; Ivanka Ristanovic; Sekine Ozturk; Jessica Turner; Theo G M van Erp; Vijay Anand Mittal
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

5.  Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study.

Authors:  Wendy R Kates; Kevin M Antshel; Stephen V Faraone; Wanda P Fremont; Anne Marie Higgins; Robert J Shprintzen; Jo-Anna Botti; Lauren Kelchner; Christopher McCarthy
Journal:  Biol Psychiatry       Date:  2010-12-31       Impact factor: 13.382

6.  Altered resting-state functional connectivity in young children at familial high risk for psychotic illness: A preliminary study.

Authors:  Sheeba Arnold Anteraper; Guusje Collin; Xavier Guell; Timothy Scheinert; Elena Molokotos; Maria Toft Henriksen; Raquelle Mesholam-Gately; Heidi W Thermenos; Larry J Seidman; Matcheri S Keshavan; John D E Gabrieli; Susan Whitfield-Gabrieli
Journal:  Schizophr Res       Date:  2019-12-02       Impact factor: 4.939

7.  Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.

Authors:  Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti
Journal:  Psychiatry Res       Date:  2013-10-22       Impact factor: 3.222

8.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects.

Authors:  Sander V Haijma; Neeltje Van Haren; Wiepke Cahn; P Cédric M P Koolschijn; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2012-10-05       Impact factor: 9.306

9.  Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia.

Authors:  Henning Witthaus; Ute Mendes; Martin Brüne; Seza Ozgürdal; Georg Bohner; Yehonala Gudlowski; Peter Kalus; Nancy Andreasen; Andreas Heinz; Randolf Klingebiel; Georg Juckel
Journal:  J Psychiatry Neurosci       Date:  2010-01       Impact factor: 6.186

10.  Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia.

Authors:  Yujiro Yoshihara; Genichi Sugihara; Hideo Matsumoto; John Suckling; Katsuhiko Nishimura; Takao Toyoda; Haruo Isoda; Kenji J Tsuchiya; Kiyokazu Takebayashi; Katsuaki Suzuki; Harumi Sakahara; Kazuhiko Nakamura; Norio Mori; Nori Takei
Journal:  Ann Gen Psychiatry       Date:  2008-12-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.